EP 1539689 A2 20050615 - ANTISENSE MODULATION OF ENDOTHELIAL LIPASE EXPRESSION
Title (en)
ANTISENSE MODULATION OF ENDOTHELIAL LIPASE EXPRESSION
Title (de)
ANTISENSE-MODULATION DER EXPRESSION VON ENDOTHELLIPASE
Title (fr)
MODULATION ANTISENS DE L'EXPRESSION DE LIPASE ENDOTHELIALE
Publication
Application
Priority
- US 0322410 W 20030718
- US 39710602 P 20020719
Abstract (en)
[origin: WO2004009541A2] Antisense compounds, compositions and methods are provided for modulating the expression of Endothelial Lipase (EL). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding EL. Methods of using these compounds for modulation of EL expression and for treatment of diseases associated with expression of EL are provided.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A01N 43/04 (2006.01); A61K 31/7088 (2006.01); A61K 31/7115 (2006.01); A61K 31/712 (2006.01); A61K 31/7125 (2006.01); A61K 48/00 (2006.01); A61P 3/00 (2006.01); A61P 3/06 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 43/00 (2006.01); C07D 201/00 (2006.01); C07H 21/04 (2006.01); C12N 5/00 (2006.01); C12N 15/113 (2010.01)
IPC 8 main group level
C07D (2006.01)
CPC (source: EP)
A61P 3/00 (2017.12); A61P 3/06 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 43/00 (2017.12); C12N 15/1137 (2013.01); C12Y 301/01003 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3341 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01); Y02P 20/582 (2015.11)
Citation (search report)
See references of WO 2004009541A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004009541 A2 20040129; WO 2004009541 A3 20040521; EP 1539689 A2 20050615; JP 2005533505 A 20051110
DOCDB simple family (application)
US 0322410 W 20030718; EP 03765691 A 20030718; JP 2004523535 A 20030718